Denture applicators with 125I seeds for treatment of palatal malignant tumors
10.3760/cma.j.cn431274-20210611-00647
- VernacularTitle:125I义齿基托布源器在腭部恶性肿瘤中的临床应用
- Author:
Jinbo BAI
1
;
Chao ZHOU
;
Wei ZHOU
;
Lianpin YU
;
Xiaohui HAN
;
Xinchun JIAN
;
Weidong ZHANG
Author Information
1. 山东第一医科大学附属省立医院口腔颌面外科，济南 250012
- Keywords:
Iodine radioisotopes;
Palatal neoplasms;
Denture bases;
Brachytherapy
- From:
Journal of Chinese Physician
2021;23(11):1611-1615
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the clinical application and curative effect of brachytherapy of denture applicators with 125I seeds in the treatment of palatal malignant tumor. Methods:Thirty patients with palatal malignant tumor who underwent surgical resection in Shandong Provincial Hospital from February 2012 to January 2020, and brachytherapy was performed with applicator additional 125I seeds 2 weeks after surgery. All patients were followed up for treatment effect and adverse reactions. Results:All patients wore 125I seeds denture base denture applicator well, no 125I seeds displacement and loss. 30 patients had 10-60 months of follow-up, among which 1 patient received palliative treatment with 125I seeds denture applicator alone died after 10 months of follow-up; 1 patient with adenoid cystic carcinoma recurred after 2 years of follow-up and underwent surgical treatment again; the rest patients did not see tumor recurrence or metastasis. The side effects, pronunciation and chewing function were improved in patients ( P<0.05). Conclusions:For patients with palatal malignant tumor, postoperative 125I seeds denture applicator can effectively prevent tumor recurrence and metastasis, reduce complications, and improve the quality of life.
